US President Donald Trump Signals Tariffs On Drug And Chip Imports By Month-End, Cites National Security Concerns

US President Donald Trump Signals Tariffs On Drug And Chip Imports By Month-End, Cites National Security Concerns

Trump made the remarks, suggesting that his administration will phase in the tariffs on pharmaceuticals to allow time for companies to construct their production facilities in the United States, reports Yonhap news agency.

IANSUpdated: Wednesday, July 16, 2025, 10:48 AM IST
article-image
US president Donald Trump | File Pic

Washington: US President Donald Trump has said his administration might start imposing tariffs on pharmaceutical imports at the end of the month, while noting the timeline for duties on semiconductors was "similar" to that of those on pharmaceuticals.

Trump made the remarks, suggesting that his administration will phase in the tariffs on pharmaceuticals to allow time for companies to construct their production facilities in the United States, reports Yonhap news agency.

"Probably at the end of the month and we are going to start off with a low tariff and give pharmaceutical companies a year or so to build, and then we're going to make it a very high tariff," he said during a press availability after returning from a public event in Pittsburgh.

Trump also said his timeline for implementing tariffs on semiconductors was “similar” and that it was “less complicated” to impose levies on chips, without providing additional detail.

Last week, Commerce Secretary Howard Lutnick said that the Trump administration will complete its national security probes into semiconductor and pharmaceutical imports at the end of this month -- an indication that Trump's tariff announcements on the imports might be approaching.

Lutnick was referring to the investigations that he initiated in April under Section 232 of the Trade Expansion Act of 1962. Under the law, the president is provided with authority to adjust imports into the U.S. when he determines they threaten to impair national security.

At a Cabinet meeting earlier this month, Trump said he planned to impose a 50 per cent tariff on copper in the coming weeks, and that he expected pharmaceutical tariffs to grow as high as 200 per cent after giving companies a year to bring manufacturing back to the US.

Trump has already announced investigations under Section 232 of the Trade Expansion Act of 1962 on drugs, arguing a flood of foreign imports was threatening national security.

(Except for the headline, this article has not been edited by FPJ's editorial team and is auto-generated from an agency feed.)

RECENT STORIES

Gold Prices Hit Record ₹1.07 Lakh Per 10 Grams In Delhi Amid Fed Rate Hopes, Geopolitical Tensions

Gold Prices Hit Record ₹1.07 Lakh Per 10 Grams In Delhi Amid Fed Rate Hopes, Geopolitical Tensions

India-EFTA Free Trade Agreement To Take Effect On October 1, Promises $100 Billion Investment

India-EFTA Free Trade Agreement To Take Effect On October 1, Promises $100 Billion Investment

Arkade Developers Buys 14,364 Sq Metre Land In Bhandup For ₹148 Crore To Expand MMR Projects

Arkade Developers Buys 14,364 Sq Metre Land In Bhandup For ₹148 Crore To Expand MMR Projects

GST Council 56th Meeting: GST Council’s Big Move Ahead? Tax Rules May Change For Pan Masala &...

GST Council 56th Meeting: GST Council’s Big Move Ahead? Tax Rules May Change For Pan Masala &...

Markets Rebound On Metal Rally, Sensex Ends 410 pts Higher Amid GST Buzz

Markets Rebound On Metal Rally, Sensex Ends 410 pts Higher Amid GST Buzz